DYN ▼ -5.1% - Dyne Therapeutics, Inc.
$DYN downgraded to Underweight at JPMorgan. PT $10
JPMorgan downgraded Dyne Therapeutics to Underweight and set a $10 price target on the stock, prompting today's 5.1% decline. The downgrade and lower-than-current price target reflect the analyst firm's reduced confidence in the company's near-term prospects.
09-SEP-2026 07:42 AM ET
Share this post
More filings for $DYN
DYN ▲ +1.0% - Dyne Therapeutics, Inc.Sep 29, 2026DYN ▲ +4.3% - Dyne Therapeutics, Inc.Sep 17, 2026DYN ▼ -28.5% - Dyne Therapeutics, Inc.Sep 8, 2026DYN ▲ +0.4% - Dyne Therapeutics, Inc.Sep 3, 2026DYN ▼ -0.1% - Dyne Therapeutics, Inc.Sep 2, 2026DYN - Dyne Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $DYN filing history →💬 Comments
Loading comments…
Leave a comment